Immune Reprograming News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immune Reprograming. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immune Reprograming Today - Breaking & Trending Today

U.S. FDA Accepts COUR Pharmaceuticals Investigational New Drug Application (IND) for a Proof-of-Concept Study for the Treatment of Primary Biliary Cholangitis (PBC)

Published: October 4, 2021

/PRNewswire/ -- COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders today announced...

Source: prnewswire.com

Related Topics:

United StatesNorthwestern UniversityJohn PuisisJulie FergusonM Eric GershwinStephend MillerJudye Guggenheim Research Professor Of MicrobiologyProfessor Of Medicine At University CaliforniaTakeda Pharmaceutical CompanyPrimary Biliary CholangitisImmune ReprogramingDistinguished ProfessorResearch ProfessorCour Pharmaceuticals